HomeNewsBusinessReal EstateReturn to work: After a gap of two years, 35% companies see 75% employees returning to office

Return to work: After a gap of two years, 35% companies see 75% employees returning to office

Consulting and telecom companies have the highest rate of return to office; 80 percent of e-commerce companies have witnessed only up to 50 percent rate of return among employees

August 03, 2022 / 18:33 IST
Story continues below Advertisement
Representative Image (Awfis)
Representative Image (Awfis)

After almost three waves of COVID-19, about 35 percent of office occupiers have seen almost 75 to 100 percent of employees returning to offices. This includes the hybrid way of working wherein employees come into the office a few times a week, according to a C-Suite Survey conducted by Colliers and Awfis.

Telecom and Consulting sectors see the highest (75-100 percent) rate of return to office. Sectors with the lowest (0-25 percent) rate of return are IT and new technology companies, it noted.

Story continues below Advertisement

As many as 41 percent of occupiers stated that up to 25 percent of their employees have returned to office. Mid-sized firms have reported a relatively higher rate of return, stating that 75-100 percent of employees have returned to work, the survey said.

As many as 80 percent of e-commerce companies have witnessed only up to 50 percent rate of return among employees, it said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show